Hanson & Doremus Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Hanson & Doremus Investment Management's IDXX Position: Q1 2023 in Review
Hanson & Doremus Investment Management sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 4 shares — an estimated $2K sold.
Hanson & Doremus Investment Management first reported a position in IDXX in Q4 2015 and held it in 29 quarters. The position peaked at $38K in Q1 2018. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.
- Hanson & Doremus Investment Management reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
- Hanson & Doremus Investment Management sold 4 Idexx Laboratories shares in Q1 2023, an estimated $2K.
- Hanson & Doremus Investment Management first reported a position in Idexx Laboratories in Q4 2015 and held it in 29 quarters.
- Hanson & Doremus Investment Management's Idexx Laboratories position peaked at $38K in Q1 2018.
- 1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.
Based on Hanson & Doremus Investment Management's 13F filing for Q1 2023, filed 18 Apr 2023.